Loading organizations...

Lumeon is a technology company.
Lumeon has raised $97.9M across 6 funding rounds.
Lumeon has raised $97.9M in total across 6 funding rounds.
Lumeon is a digital health company dedicated to helping provider organizations mend broken care coordination processes through automated care orchestration.
Lumeon has raised $97.9M in total across 6 funding rounds.
Lumeon's investors include Alexander Schmitz, Ashish Patel, Amadeus Capital Partners, IPF Partners, LSP, MTIP, Rudy De Keyser, Cedars-Sinai Medical Center, EQT Life Sciences, Forbion, Techstars, Archimedia Investments.
Lumeon is a digital health company specializing in a cloud-based care orchestration platform that automates clinical workflows, integrating real-time data from EHRs and other systems to deliver personalized patient care[1][2][3][4]. It serves major hospitals and health systems in the U.S. and Europe, including over 70 customers like BUPA, Nuffield Health, and HCA, solving problems of care fragmentation, clinician burnout, manual tasks, and inefficiencies in areas such as scheduling, perioperative care, inpatient management, and ambulatory services[1][2][4]. By operationalizing clinical best practices, Lumeon reduces costs by up to 20% per case, boosts care team capacity by 66%, and cuts charting time by 83%, enabling providers to scale best practices and focus on high-value patient care amid staffing shortages[2][4].
Founded in 2005 and headquartered in Boston with roots in London, Lumeon has grown to over 130 employees and $19.1 million in revenue, earning accolades like "Best Care Orchestration Platform" from MedTech Breakthrough Awards and partnerships such as Panda Health[1][2][3].
Lumeon was founded in 2005, initially pioneering Care Pathway Management (CPM) to address systemic inefficiencies in healthcare delivery beyond isolated symptoms[1][3]. Emerging from the need to orchestrate end-to-end care—from scheduling and revenue management to clinical reporting and aftercare—the company established itself as a market leader, particularly in Europe with innovative providers like BUPA, Nuffield Health, Alliance Medical, HCA, Optegra, and Newmedica[1]. Early traction came from its holistic approach, employing over 90 people in London before expanding to the U.S., with headquarters now at One Lincoln St., Boston[1][3]. Pivotal moments include recent awards and integrations, such as Panda Health partner status in 2024 and recognition for preoperative readiness innovations, solidifying its 15+ years of leadership in care automation[2][4][5].
Lumeon rides the wave of clinical workflow automation and AI-driven healthcare orchestration, addressing post-pandemic pressures like clinician burnout, staffing shortages, and rising costs amid value-based care shifts[2][4]. Its timing aligns with health systems' urgent need to virtualize processes—such as preoperative readiness and Hospital at Home—boosting capacity without proportional staff increases, as evidenced by its virtualization tools increasing surgical throughput[4][5]. Market forces like EHR interoperability mandates and automation demands favor Lumeon, influencing the ecosystem by setting standards for care pathway management, enabling providers to eliminate fragmentation, and paving the way for scalable, patient-centric models adopted by leading U.S. and European systems[1][2].
Lumeon is poised to expand its platform amid accelerating AI adoption in healthcare, targeting deeper integrations for predictive analytics and enterprise-wide orchestration to capture more of the $20B+ clinical workflow market. Trends like workforce automation and personalized medicine will propel growth, potentially doubling its customer base as health systems prioritize ROI from tools slashing costs and burnout. Its influence may evolve from niche leader to essential infrastructure, empowering care teams to deliver efficient, high-touch care at scale—transforming fragmented systems into orchestrated powerhouses, much like its foundational mission to address healthcare's root inefficiencies.
Lumeon has raised $97.9M across 6 funding rounds. Most recently, it raised $30.0M Series D in August 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 11, 2020 | $30.0M Series D | Alexander Schmitz, Ashish Patel | Amadeus Capital Partners, IPF Partners, LSP, MTIP |
| Dec 4, 2018 | $28.0M Other Equity | Rudy De Keyser | Amadeus Capital Partners, Cedars-Sinai Medical Center, IPF Partners, MTIP |
| Dec 1, 2018 | $28.0M Series C | EQT Life Sciences, Forbion | |
| Sep 1, 2017 | $120K Venture Round | Techstars | |
| Jun 9, 2015 | $9.2M Series B | Amadeus Capital Partners, Archimedia Investments | |
| Nov 5, 2012 | $2.6M Other Equity | Alex van Someren, John Hunt |